Skip to content
healthcare.dev

OLMESARTAN MEDOXOMIL

NDC 49252-065, olmesartan medoxomil, tablet, coated, from Inventia Healthcare Limited.

Product NDC
49252-065
Status
Listed
Labeler
Inventia Healthcare Limited
Dosage form
TABLET, COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208659
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/49252-065 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OLMESARTAN MEDOXOMIL5 mg/1

Pharmacologic classes

Angiotensin 2 Receptor Antagonists [MoA]; Angiotensin 2 Receptor Blocker [EPC]

Package NDCNDC-11Package
49252-065-104925200651030 TABLET, COATED in 1 BOTTLE (49252-065-10)
49252-065-124925200651290 TABLET, COATED in 1 BOTTLE (49252-065-12)
49252-065-18492520065181000 TABLET, COATED in 1 BOTTLE (49252-065-18)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/05a807bf-5175-43a2-a676-215bba2645a8

Use it

Look up 49252-065 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/49252-065 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 49252-065. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.